CLINICAL TRIALS PROFILE FOR TEMOVATE E

All Clinical Trials for TEMOVATE E

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00297011 ↗	Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis	Completed	GlaxoSmithKline	Phase 2	2004-09-01	A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
NCT00297011 ↗	Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis	Completed	University of Utah	Phase 2	2004-09-01	A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores).
NCT00470392 ↗	Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis	Terminated	University Hospitals Cleveland Medical Center	N/A	2007-05-01	The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes
NCT00470392 ↗	Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis	Terminated	VA Office of Research and Development	N/A	2007-05-01	The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes

Clinical Trial Conditions for TEMOVATE E

Condition Name

Condition Name for TEMOVATE E
Intervention	Trials
Herpes Labialis	1
Psoriasis	1

Condition MeSH

Condition MeSH for TEMOVATE E
Intervention	Trials
Herpes Labialis	1
Psoriasis	1

Clinical Trial Locations for TEMOVATE E

Trials by Country

Trials by Country for TEMOVATE E
Location	Trials
United States	2

Trials by US State

Trials by US State for TEMOVATE E
Location	Trials
Ohio	1
Utah	1

Clinical Trial Progress for TEMOVATE E

Clinical Trial Phase

Clinical Trial Phase for TEMOVATE E
Clinical Trial Phase	Trials
Phase 2	1
N/A	1

Clinical Trial Status

Clinical Trial Status for TEMOVATE E
Clinical Trial Phase	Trials
Completed	1
Terminated	1

Clinical Trial Sponsors for TEMOVATE E

Sponsor Name

Sponsor Name for TEMOVATE E
Sponsor	Trials
GlaxoSmithKline	1
University of Utah	1
University Hospitals Cleveland Medical Center	1

Sponsor Type

Sponsor Type for TEMOVATE E
Sponsor	Trials
Other	2
Industry	1
U.S. Fed	1